Bellwether Advisors’s Filana Therapeutics FLNA Stock Holding History

Bellwether Advisors’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-27,769	Closed	-$1.72M	–	601
2021 Q3	$1.72M	Buy	+27,769	New	+$2.32M	0.57%	39

Other funds holding FLNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Bellwether Advisors's FLNA Position: Q4 2021 in Review

Bellwether Advisors sold out of Filana Therapeutics (FLNA) in Q4 2021, closing a stake of 27,769 shares — an estimated $1.72M sold.

Bellwether Advisors first reported a position in FLNA in Q3 2021 and held it in 1 quarter. The position peaked at $1.72M in Q3 2021. 171 funds tracked by Wall St. Rank hold FLNA as of Q4 2021.

Bellwether Advisors reported no remaining Filana Therapeutics position as of Q4 2021 after selling out during the quarter.
Bellwether Advisors sold 27,769 Filana Therapeutics shares in Q4 2021, an estimated $1.72M.
Bellwether Advisors first reported a position in Filana Therapeutics in Q3 2021 and held it in 1 quarter.
Bellwether Advisors's Filana Therapeutics position peaked at $1.72M in Q3 2021.
171 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2021.

Based on Bellwether Advisors's 13F filing for Q4 2021, filed 28 Jan 2022.